Although our study does not suggest the A2AR as a primary pathophysiological target in schizophrenia, the close interaction of A2AR with D2 receptors does not exclude a potential role for the manipulation of this receptor as a potential pharmacological target in the treatment of this disorder Fig. 1. The gene discussed is ADORA2A; the disease is schizophrenia.